Dr. Arianna Bresci is a postdoctoral associate at the Massachusetts Institute of Technology, supported by Apollon, Inc. She conducts research, development, and clinical studies of Raman spectroscopy-based systems for health management, together with non-invasive imaging technology for biomedical and biological discovery. In 2024, she earned a Ph.D. in Physics with honors from Politecnico di Milano, Italy, during which she was a Rocca Doctoral Fellow at MIT. Previously, she received both her Master’s and Bachelor’s degrees in Biomedical Engineering from Politecnico di Milano.
Dr. Bresci has authored more than 20 peer reviewed journal publications in biophotonics, spectroscopy, and biomedical imaging, and she is an inventor on 2 United States patents in optical sensing technologies. In 2025, she received the SPIE Advanced Biophotonics Young Investigator Award and was elected to the global cohort of the 2026 SPIE Women in Optics.
Her scientific interests focus on advancing biophotonics technologies for intelligent biomedicine.
Building on the first direct observation of glucose Raman signals from in-vivo skin, MIT researchers are advancing band-pass Raman spectroscopy as a path toward truly non-invasive, physiological-level continuous glucose monitoring in a compact optical device. In this session, the team will introduce the band-pass Raman system, share recent human-trial results, and explore how wearable Raman-based CGM devices could redefine diabetes management and continuous metabolic monitoring.